Life Sciences Alternative Funding

Life Sciences Alternative Funding (LSAF) provides non-dilutive, debt capital exclusively to fund the growth of commercial-stage life sciences companies with a primary focus on medical device and diagnostics companies. LSAF's highly flexible structures provide long-term capital solutions ranging from $10 million to $50 million or more. LSAF is majority-owned by affiliates of the Perella Weinberg Partners Asset Based Value Strategy.

Life Sciences Alternative Funding (LSAF) provides non-dilutive, debt capital exclusively to fund the growth of commercial-stage life sciences companies with a primary focus on medical device and diagnostics companies. LSAF's highly flexible structur...Show all

See All Exits Recent Exits

Phone:

Fax:



New York,
New York, United States

Life Sciences Alternative Funding - Investments & Acquisitions

Show Real Data Life Sciences Alternative Funding Investments